Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccinationRahul K. Suryawanshi(Gladstone Institutes), Mélanie Ott(Gladstone Institutes)NatureMay 18, 202210.1038/s41586-022-04865-0Cited by 213SaveCiteExport RISWatch citationsRelated PapersNeuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons|mBio|2022|129Fibrin drives thromboinflammation and neuropathology in COVID-19|Nature|2024|95Rapid assembly of SARS-CoV-2 genomes reveals attenuation of the Omicron BA.1 variant through NSP6|Nature Communications|2023|69Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination|medRxiv|2022|35A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo|PLoS Pathogens|2023|35